DomaniCell now Collecting and Banking Immune System and Stem Cells for the Entire Family
News Aug 17, 2007
DomaniCell, LLC (DomaniCell), a service provider in the field of cell collection, processing, storage and therapies, is now expanding its service to the collection and storage of stem cells and immune system cells for adults who choose to proactively store their cells, while they are healthy and younger, for potential future use.
Collecting and banking one’s stem cells and immune system cells is an increasingly important part of a proactive wellness plan. Such a plan is intended to take advantage of the growing number of regenerative and therapeutic treatments currently available and in development that utilize stem cells and cells of the immune system.
When collected and stored from younger and healthier donors, stem cells and immune system cells are more effective than those collected later in life or from a donor suffering from an illness or genetic disorder.
Additionally, autologous (self) stem cell and immune system cell replacement has been demonstrated to be highly effective in restoring normal function after exposure to toxins, including radiation.
DomaniCell is part of Progenitor Cell Therapy LLC, a cell therapy development, manufacturing and distribution services company.
“DomaniCell and Progenitor Cell Therapy together provide an unmatched depth and breadth of experience in the collection, manufacturing, storage and delivery of human cells for clinical use,” states Chairman Andrew L. Pecora, MD.
“Our group of companies has provided cell therapy manufacturing, storage and delivery services for more patients treated with a cell therapy product than any company in the world. We have developed expertise in over 20 different types of cell-based therapeutics including cell-based therapies for brain and spinal cord repair, cardiovascular disease, diabetes and cancer and other regenerative medicines.”
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.